PT Kino Indonesia Tbk

PT Kino Indonesia Tbk

KINO.JK
PT Kino Indonesia TbkID flagIndonesia Stock Exchange
1,125.00
IDR
-5.00
- -
1.55TMarket Cap
PT Kino Indonesia Tbk
KINO.JK
(Indonesia Stock Exchange)

Recent

price

1,125.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
3,601.35
3,202.06
2,445.12
2,212.45
2,528.19
3,275.21
2,817.48
2,783.66
2,607.07
2,999.8
3,167.56
3,206.77
3,162.51
Revenue per Share
- -
112.15
233.65
126.42
77.29
105.1
364.31
79.59
73.53
-687.06
51.1
62.81
89.71
79.56
Basic EPS, GAAP
- -
-196.03
-95.83
-118.11
-38.24
-139.08
-298.6
-266.86
-260.33
-207.68
-155.8
-91.82
-151.3
-139.35
Free Cash Flow per Basic Share
- -
46.16
- -
37
25
27
57
103
24.29
10.38
0.73
22.73
33.44
- -
Dividend per Share
- -
344.51
521.36
486.49
535.86
618.19
920.63
860.36
909.61
231.3
336.12
391.92
447.8
399.11
Book Value per Share
- -
714.35
1,578.55
1,366.45
1,438.62
1,530.83
1,892
1,764.96
1,809.94
1,030.89
1,106.09
1,135.61
1,210.11
1,149.62
Tangible Book Value per Share
- -
927
1,125
1,429
1,429
1,429
1,429
1,429
1,429
1,393
1,379
1,379
1,379
1,379
Basic Weighted Avg Shares
- -
3,339,386
3,603,848
3,493,029
3,160,637
3,611,694
4,678,869
4,024,971
3,976,656
3,631,451
4,136,182
4,367,489
4,421,550
4,360,533
Sales/Revenue/Turnover
- -
5.63
12.04
6.98
5.99
6.87
9.38
5.54
5.83
-14.06
5.25
4.45
4.82
4.37
Operating Margin (%)
- -
- -
- -
17,838
18,637
17,692
23,131
51,082
68,179
70,434
61,959
63,492
54,489
58,810
Depreciation Expense
- -
103,996
262,971
180,602
110,417
150,149
520,444
113,697
105,043
-957,026
70,463
86,599
123,698
109,695
Net Income, GAAP
- -
24.92
21.95
17.42
22.18
25.09
18.94
15.9
20.8
- -
32.03
16.78
20.48
7.32
Effective Tax Rate (%)
- -
3.11
7.3
5.17
3.49
4.16
11.12
2.82
2.64
-26.35
1.7
1.98
2.8
2.52
Profit Margin (%)
-143,321
-201,822
798,875
655,379
709,839
661,417
601,904
415,847
806,626
-247,164
-367,008
-616,923
-795,417
-772,275
Working Capital
53,706
70,438
87,578
48,008
20,323
4,125
145,988
373,819
963,431
1,085,579
773,387
462,274
186,331
301,200
LT Debt
461,192
662,385
1,776,629
1,952,072
2,055,171
2,186,900
2,702,862
2,614,062
2,688,443
1,533,820
1,618,730
1,650,361
1,746,342
1,666,303
Total Equity
- -
13
17.09
7.5
5.48
6.83
10.7
4.64
4.21
- -
4.25
4.93
5.2
5.4
Return on Invested Capital (%)
- -
19.41
28.14
17.65
11.58
13.36
29.6
8.11
7.34
- -
6.97
8.62
9.94
9.89
Return on Capital (%)
- -
40.38
58.04
28.18
15.12
18.21
47.35
8.94
8.31
-118.03
17.94
17.25
21.37
21.64
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
1,320,856
1,348,706
1,482,028
LT Borrowings
429,732
343,157
268,747
LT Finance Leases
32,542
32,286
32,453
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,379
1,379
1,379
Market Capitalization
1,654,583
1,530,489
1,447,760

Working Capital

FRC

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
1,627,935
1,779,288
1,696,798
Cash, Cash Equivalents & STI
121,213
118,816
154,958
Accounts Receivable, Net
911,248
1,031,358
938,947
Inventories
464,488
475,959
465,369
Total Current Liabilities
2,244,859
2,439,723
2,469,073
Payables & Accruals
- -
- -
- -
ST Debt
1,320,856
1,348,706
1,482,028
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.51%
-5.36%
5.82%
Free Cash Flow
32.99%
-5.34%
64.78%
Net Income, GAAP
-92.6%
-212.06%
42.84%
Sales/Revenue/Turnover
2.81%
2.17%
1.24%
Total Cash Common Dividend
- -
563.14%
47.13%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,103,664
1,063,272
1,048,738
1,151,815
4,367,489
2025
1,127,347
1,032,633
1,228,579
- -
4,421,550
2026
1,256,024
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
12.79
- -
- -
- -
62.81
2025
28.07
- -
- -
- -
89.71
2026
45.7
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
22.73
2025
- -
- -
- -
- -
33.44
2026
- -
- -
- -
- -
- -
Business
PT Kino Indonesia Tbk stands as a prominent Indonesian fast-moving consumer goods entity, dedicated to the production and global distribution of an extensive array of personal care items, diverse beverages, food products, pharmaceutical offerings, and pet nourishment. The company's vibrant personal care division encompasses a wide range of solutions, including haircare lines such as Ellips, Sasha, and Samantha, alongside oral care products like Sasha and Click. Skin health is addressed through Ovale and Ristra, while Sleek Baby caters to infant care. Its portfolio also features Abstract decoratives, Eskulin fragrances, feminine hygiene essentials like Resik V and Absolute, and specialized personal care for children under the B&B Kids, Eskulin Kids, and Master Kids banners. Master brand products serve men's grooming needs, with Evergreen supplying air fresheners and Sleek and Instance Hand Sanitizer providing hygiene solutions. The MAXLife, Perro, KUCINGKU, and JOJO brands cater to the pet food market. Beyond personal care, Kino Indonesia offers a significant selection of beverages, including cooling remedy drinks like Cap Kaki Tiga and Larutan Sejuk Segar. Health-focused options are available through the Cap Panda brand, while Panther provides energy drinks, and the Malee brand (via a joint venture) delivers canned fruits, coconut water, and various juices. The company's food segment delights consumers with confectionery items such as Kino Candy, Oplozz, Frenta Candy, and Chew Chew Ball candies, alongside Snack It and Kino Nastar snacks, and Segar Sari powdered drinks. In the pharmaceutical space, Kino presents herbal cough remedies, balms, headache relievers, and treatments for skin conditions under the Cap Kaki Tiga and Q-Life labels, complemented by herbal products from Dua Putri Dewi. Established in 1999 and headquartered in Tangerang, Indonesia, the enterprise consistently pursues strategic expansion, both domestically and internationally, leveraging its wide distribution network across Indonesia and into various global regions including Asia, the Middle East, Russia, and Africa. With "Innovation is Our DNA" as a core principle, Kino emphasizes continuous product development, meeting evolving consumer demands, and strengthening its position as a relevant and cherished brand across generations. Recent activities underscore this commitment, with brands like Eskulin celebrating milestones and receiving awards for innovative marketing, and Ristra Clinic broadening its services with wellness programs. The company also engages in community and environmental initiatives, reflecting its dedication to social and governance pillars. PT Kino Indonesia Tbk operates as a subsidiary of PT Kino Investindo.